Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.64 USD | 0.00% | +52.64% | -10.12% |
May. 15 | Sector Update: Health Care Stocks Advance Late Wednesday Afternoon | MT |
May. 15 | T2 Biosystems Shares Rise After CRG Servicing Ups Stake | MT |
Financials (USD)
Sales 2024 * | 10.5M | Sales 2025 * | 23.1M | Capitalization | 86.66M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -47M | EV / Sales 2024 * | 8.25 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.75 x |
P/E ratio 2024 * |
-1.53
x | P/E ratio 2025 * |
-4.03
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.09% |
Latest transcript on T2 Biosystems, Inc.
1 week | +52.64% | ||
Current month | +68.11% | ||
1 month | +88.63% | ||
3 months | +3.49% | ||
6 months | +44.62% | ||
Current year | -10.12% |
Managers | Title | Age | Since |
---|---|---|---|
John Sperzel
CEO | Chief Executive Officer | 60 | 20-01-07 |
John Sprague
DFI | Director of Finance/CFO | 65 | 18-01-29 |
Roger Smith
CTO | Chief Tech/Sci/R&D Officer | 59 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Elsbree
BRD | Director/Board Member | 76 | 14-06-30 |
Seymour Liebman
BRD | Director/Board Member | 74 | 16-09-20 |
Robin Toft
BRD | Director/Board Member | 63 | 20-06-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 5.64 | 0.00% | 180,329 |
24-05-16 | 5.64 | -5.53% | 662,387 |
24-05-15 | 5.97 | +43.51% | 3,152,259 |
24-05-14 | 4.16 | -5.24% | 453,389 |
24-05-13 | 4.39 | +18.81% | 629,776 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.12% | 86.66M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- TTOO Stock